Search - tctmd.com

Displaying 701 - 720 of 963

Sort: Relevancy | Date

News Daily News

Bivalirudin Safer Than Heparin Alone in ‘Real-World’ PCI Patients Without STEMI

Yael L. Maxwell

May 01, 2014

Presentation

ACC 2014 Late Breaking Trials Renal Denervation for Resistant Hypertension

Presenter: Gregg W. Stone

April 28, 2014

News Conference News ACC 2014

CHAMPION PHOENIX Analysis: Cangrelor Reduces Early Stent Thrombosis, Suggesting Mortality Benefit

April 02, 2014

News Conference News ACC 2014

ZES Plus Tailored Course of Dual Therapy Reduces Adverse Events in Unlikely DES Candidates

Yael L. Maxwell

March 31, 2014

News Conference News ACC 2014

NEXT at 2 Years: Nobori DES Still Noninferior to Xience/Promus

Jason Kahn

March 31, 2014

News Conference News ACC 2014

HEAT PPCI: Results Favoring Heparin over Bivalirudin Raise Scientific, Ethical Issues

Jason Kahn

March 31, 2014

News Conference News ACC 2014

CHOICE Trial, TVT Registry Shed Light on Evolving TAVR Outcomes, Risks

L.A. McKeown

March 31, 2014

Presentation PCI Outcomes 2014

Perspectives on PCI vs CABG in the Diabetic Patient: The FREEDOM to Disagree with FREEDOM

Presenter: Gregg W. Stone

March 28, 2014

Presentation CIT 2014

From Coronary Revascularization to Vascular Restoration:Why Do We Need BRS?

Presenter: Gregg W. Stone

March 20, 2014

News Daily News

Los Resultados SLF Varían según el Estado de la Diabetes y la Complejidad de la Lesión

Caitlin E. Cox

March 13, 2014

News Daily News

DES Outcomes Vary by Diabetes Status, Lesion Complexity

Caitlin E. Cox

March 13, 2014

News Industry News

Abbott Completes Enrollment of Absorb™ Randomized Clinical Trials in the United States, Japan and China

March 10, 2014

Presentation CTO 2014

EXCEL and NOBLE: Where do Left Main Trials Stand in the Shadows of SYNTAX and FREEDOM?

Presenter: Gregg W. Stone

March 01, 2014

News Daily News

NCDR Data Show Post-PCI Transfusion Linked with Poor Outcomes

L.A. McKeown

February 26, 2014

News Daily News

Los Datos del NCDE Revelan que las Transfusiones post-PCI acarrean Malos Resultados

L.A. McKeown

February 26, 2014

News Daily News

Moderate/Severe Calcification in ACS Patients Linked to Worse Post-PCI Outcomes

Yael L. Maxwell

February 20, 2014

News Daily News

La Calcificacion Moderada/Severa en Pacientes SCA se asocia a Peores Resultados Post-PCI

Yael L. Maxwell

February 20, 2014

News Daily News

ACS患者的中度/重度钙化会导致PCI后结果恶化

Yael L. Maxwell

February 20, 2014

News Daily News

Un Panel de la FDA Rechaza el Cangrelor para las Indicaciones PCI y Terapia Puente

Yael L. Maxwell

February 13, 2014

News Daily News

FDA Panel Rejects Cangrelor for Both PCI, Bridging Indications

Yael L. Maxwell

February 13, 2014

Advertisement

Bivalirudin Safer Than Heparin Alone in ‘Real-World’ PCI Patients Without STEMI

ACC 2014 Late Breaking Trials Renal Denervation for Resistant Hypertension

CHAMPION PHOENIX Analysis: Cangrelor Reduces Early Stent Thrombosis, Suggesting Mortality Benefit

ZES Plus Tailored Course of Dual Therapy Reduces Adverse Events in Unlikely DES Candidates

NEXT at 2 Years: Nobori DES Still Noninferior to Xience/Promus

HEAT PPCI: Results Favoring Heparin over Bivalirudin Raise Scientific, Ethical Issues

CHOICE Trial, TVT Registry Shed Light on Evolving TAVR Outcomes, Risks

Perspectives on PCI vs CABG in the Diabetic Patient: The FREEDOM to Disagree with FREEDOM

From Coronary Revascularization to Vascular Restoration:Why Do We Need BRS?

Los Resultados SLF Varían según el Estado de la Diabetes y la Complejidad de la Lesión

DES Outcomes Vary by Diabetes Status, Lesion Complexity

Abbott Completes Enrollment of Absorb™ Randomized Clinical Trials in the United States, Japan and China

EXCEL and NOBLE: Where do Left Main Trials Stand in the Shadows of SYNTAX and FREEDOM?

NCDR Data Show Post-PCI Transfusion Linked with Poor Outcomes

Los Datos del NCDE Revelan que las Transfusiones post-PCI acarrean Malos Resultados

Moderate/Severe Calcification in ACS Patients Linked to Worse Post-PCI Outcomes

La Calcificacion Moderada/Severa en Pacientes SCA se asocia a Peores Resultados Post-PCI

ACS患者的中度/重度钙化会导致PCI后结果恶化

Un Panel de la FDA Rechaza el Cangrelor para las Indicaciones PCI y Terapia Puente

FDA Panel Rejects Cangrelor for Both PCI, Bridging Indications

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content